🇺🇸 FDA
Patent

US 12391642

Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors

granted A61KA61K45/06A61P

Quick answer

US patent 12391642 (Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors) held by NIKANG THERAPEUTICS, INC. expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
NIKANG THERAPEUTICS, INC.
Grant date
Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K45/06, A61P, A61P35/00